HNI (HNI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 15, 2025, will be held virtually with no physical location.
Shareholders are encouraged to review proxy materials online or request paper copies at no charge.
The meeting will cover director elections, auditor ratification, and executive compensation approval.
Voting matters and shareholder proposals
Shareholders will vote on re-electing three directors: Jeffrey D. Lorenger, Larry B. Porcellato, and David M. Roberts.
Proposal to ratify KPMG LLP as the independent registered public accounting firm for the fiscal year ending January 3, 2026.
Advisory vote on approval of Named Executive Officer compensation.
Board of directors and corporate governance
Board recommends voting in favor of all proposals presented at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from HNI
- Steelcase acquisition and synergy gains fuel double-digit EPS growth and strong 2026 outlook.HNI
Q4 202525 Feb 2026 - Record Q2 profit and margin gains signal strong growth and positive outlook.HNI
Q2 20242 Feb 2026 - Synergy-driven savings and resilient margins fuel growth across both business segments.HNI
Water Tower Research Consumer Products Virtual Investor Conference 20241 Feb 2026 - Double-digit EPS growth and record margins achieved despite lower sales.HNI
Q3 202418 Jan 2026 - Record EPS and margin expansion in 2024; 2025 outlook strong despite macro volatility.HNI
Q4 202414 Dec 2025 - 2024 saw record margin expansion, KII synergy outperformance, and continued ESG leadership.HNI
Proxy Filing1 Dec 2025 - $2.2B acquisition targets $120M synergies, expanded reach, and EPS accretion by 2027.HNI
M&A Announcement23 Nov 2025 - Non-GAAP EPS up 19% on 2% sales growth; 2025 double-digit EPS growth outlook reaffirmed.HNI
Q1 202517 Nov 2025 - Q2 2025 delivered 7% sales growth and 41% EPS gain, with guidance raised for double-digit growth.HNI
Q2 202513 Nov 2025